Evaluation of albendazole prodrugs in experimental trichinellosis

Archives of Medical Research

Volumn 30, Issue 5, 1999, Pages 368-374

  Yépez Mulia, Lilián ^a   Morales Hurtado, Raúl ^a   Viveros Guzmán, Noemí ^a   Cedillo Rivera, Roberto ^a   Hernández Luis, Francisco ^b   Castillo, Rafael ^b   Hernández Campos, Alicia ^b   Muñoz, Onofre ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Albendazole prodrugs; Bioconversion; Trichinella spiralis; Trichinellosis

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; DRUG METABOLITE; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG SOLUBILITY; EXPERIMENTAL INFECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; TRICHINELLA SPIRALIS; TRICHINOSIS;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; DRUG EVALUATION, PRECLINICAL; FEMALE; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, SPRAGUE-DAWLEY; TRICHINOSIS;

EID: 0345008872     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-0128(99)00054-8     Document Type: Article

References (20)

1. Albonico M., Smith P.G., Hall A., Chwaya H.M., Alawi K.S., Savioli L. A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris, and hookworm infections. Trans R Soc Trop Med Hyg. 88:1994;585.
2. Sharma S. Design of new drugs for helminth diseases. lead optimization in benzimidazoles Adv Drug Res. 25:1994;104.
3. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int J Parasitol. 18:1988;885.
4. McCracken R.O. Efficacy of mebendazole and albendazole against Trichinella spiralis in mice. J Parasitol. 64:1978;214.
5. Delatour P., Benoit E., Besse S., Boukraa A. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats. Xenobiotica. 21:1991;217.
6. Gottschall D.W., Theodorides V.J., Wang R. The metabolism of benzimidazole anthelmintics. Parasitol Today. 6:1990;115.
7. Lacey E. Mode of action of benzimidazoles. Parasitol Today. 6:1990;112.
8. Jung H., Hurtado M., Sánchez M., Medina M.T., Sotelo J. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. J Clin Pharmacol. 32:1992;28.
9. Mariner S.E., Bogan J.A. Pharmacokinetics of albendazole in sheep. Am J Vet Res. 41:1980;1126.
10. Penicaut B., Beeck C., Maugein P.H., Parish R., Randolph W., Di Cuollo C.J., Rossignol J.F. Albendazol. Perfil farmacocinético. Compendium Inv Clin Latino. 1:1981;61.
11. Delatour P., Cure M.C., Benoit E., Garnier F. Netobimin (Totabin-SCH). preliminary investigations on metabolism and pharmacology J Vet Pharmacol Ther. 9:1986;230.
12. Silverman R.B. The Organic Chemistry of Drug Design and Drug Action. 1992;Academic Press, Philadelphia.
13. López-García ML, Susana-Torrado S, Sardaña-Ripoll MD, Bolás-Fernández F, Martínez-Fernández A. Trichinella spiralis a model for the evaluation of generic benzimidazole-carbamates. In: Campbell WC, Pozio E, Bruschi F, editors. Proceedings of The 8th International Conference on Trichinellosis. Rome: Istituto Superiore de Sanitá Press;1994. p. 423.
14. Hernández-Luis F., Castillo R., Yépez-Mulia L., Cedillo-Rivera R., Martínez G., Morales R., Jung H., Sánchez M., Hernández-Campos A., Viveros N., Muñoz O. Preparation of N-methoxycarbonyl-N′-[2-nitro-4(5)-propylthiophenyl] thiourea as prodrugs of albendazole. Bioorg Med Chem Lett. 6:1996;2231.
15. Dennis D.T., Despommier D.D., Davis N. Infectivity of the newborn larvae of Trichinella spiralis in the rat. J Parasitol. 56:1970;974.
16. Karanukaran C.S., Denham D.A. A comparison of the anthelmintic effects of oxfendazole and oxibendazole on Trichinella spiralis in mice. J Parasitol. 66:1980;929.
17. Stewart G.L., Kramar G.W., Reddington J.J., Hamilton A.M. Studies on in vitro larvaposition by adult of Trichinella spiralis. J Parasitol. 66:1980;84.
18. McCracken R.O., Nierste D.M., Moss J., García A. Oxfendazole. regimen-dependent expression of drug efficacy against Trichinella spiralis. Int J Parasitol. 14:1984;277.
19. López García M.L., Torrado-Durán S., Torrado-Durán J., Martínez-Fernández R.A., Bolás-Fernández F. Albendazole versus ricobendazole (albendazole sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice. Int J Parasitol. 27:1997;781.
20. Lindros K.O. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol. 28:1997;191.